Search Results - Barbara Pro

Refine Results
  1. 1
    Central nervous system prophylaxis in peripheral T-cell lymphoma

    Central nervous system prophylaxis in peripheral T-cell lymphoma by Barbara Pro, Guilherme Fleury Perini

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Brentuximab Vedotin in CD30+ Lymphomas

    Brentuximab Vedotin in CD30+ Lymphomas by Guilherme Fleury Perini, Barbara Pro

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    How I treat posttransplant lymphoproliferative disorder

    How I treat posttransplant lymphoproliferative disorder by Jennifer E. Amengual, Barbara Pro

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Hepatosplenic T-cell lymphoma: a rare but challenging entity

    Hepatosplenic T-cell lymphoma: a rare but challenging entity by Barbara Pro, Pamela B. Allen, Amir Behdad

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Meta–analyses of the association between <i>Chlamydia psittaci</i> and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics

    Meta–analyses of the association between <i>Chlamydia psittaci</i> and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics by Amina Husain, Dianna Roberts, Barbara Pro, Peter McLaughlin, Bita Esmaeli

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

    Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial by Francine M. Foss, Sarah McCue Horwitz, Barbara Pro, H. Miles Prince, Lubomir Sokol, Barbara Balser, Julie Wolfson, Bertrand Coiffier

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Follicular dendritic cell sarcoma: A report of 14 cases and a review of the literature

    Follicular dendritic cell sarcoma: A report of 14 cases and a review of the literature by Andres O. Soriano, Michael A. Thompson, Joan H. Admirand, Luis Fayad, Alma María Rodríguez, Jorge Romaguera, Fredrick B. Hagemeister, Barbara Pro

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment

    Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment by G. S. Falchook, Francisco Vega, Nam H. Dang, Felipe Samaniego, Maria Alma Rodriguez, Richard E. Champlin, Chitra Hosing, Srđan Verstovšek, Barbara Pro

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma

    Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma by Yasuhiro Oki, Barbara Pro, Luis Fayad, Jorge Romaguera, Felipe Samaniego, Fredrick Hagemeister, Sattva S. Neelapu, Peter McLaughlin, André Goy, Anas Younes

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma

    Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma by Elias Jabbour, Chitra Hosing, Gregory D. Ayers, Rodolfo Núñez, Paolo Anderlini, Barbara Pro, Issa F. Khouri, Anas Younes, Fredrick B. Hagemeister, Larry W. Kwak, Luis Fayad

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma

    Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma by Jia Ruan, Jasmine M. Zain, Brett Alan Palmer, Borko Jovanovic, Xinlei Mi, Alok Swaroop, Jane N. Winter, Leo I. Gordon, Reem Karmali, Jonathan Moreira, Adam M. Petrich, Barbara Pro

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

    Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma by Bita Esmaeli, Peter McLaughlin, Barbara Pro, Felipe Samaniego, Isis Gayed, Fredrick B. Hagemeister, Jorge Romaguera, Fernando Cabanillas, Sattva S. Neelapu, R. Banay, Luis Fayad, M. Wayne Saville, Larry W. Kwak

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Progression of undiagnosed cutaneous lymphoma after anti–tumor necrosis factor-alpha therapy

    Progression of undiagnosed cutaneous lymphoma after anti–tumor necrosis factor-alpha therapy by Maria Estela Martínez‐Escala, Alba Posligua, Heather Wickless, Audrey Rutherford, Kimberly A. Sable, Belén Rubio-González, Xiaolong Zhou, Jason Kaplan, Barbara Pro, Jaehyuk Choi, Christiane Querfeld, Steven T. Rosen, Joan Guitart

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Single agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma treatment (COMPLETE) registry

    Single agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma tre... by Robert Stuver, Niloufer Khan, Marc Schwartz, Mark Acosta, Massimo Federico, Christian Gisselbrecht, Steven M. Horwitz, Frederik Lansigan, Lauren Pinter‐Brown, Barbara Pro, Andrei R. Shustov, Francine M. Foss, Salvia Jain

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma

    Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma by Barbara Pro, Brian Leber, Mitchell R. Smith, Luis Fayad, Jorge Romaguera, Fredrick B. Hagemeister, Maria Alma Rodriguez, Peter McLaughlin, Felipe Samaniego, James A. Zwiebel, Adriana López, Larry W. Kwak, Anas Younes

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30<sup>+</sup> Peripheral T-Cell Lymphomas: Results of a Phase I Study

    Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30<sup>+</sup> Peripheral T-Cell Lymphomas: Results of a Phase I Study by Michelle A. Fanale, Steven M. Horwitz, Andres Forero‐Torres, Nancy L. Bartlett, Ranjana H. Advani, Barbara Pro, Robert W. Chen, Andrew Davies, Tim Illidge, Dirk Huebner, Dana A. Kennedy, Andrei R. Shustov

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Phase II Study of Yttrium-90–Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Phase II Study of Yttrium-90–Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma by Michael Wang, Yasuhiro Oki, Barbara Pro, Jorge Romaguera, Maria Alma Rodriguez, Felipe Samaniego, Peter McLaughlin, Frederick Hagemeister, Sattva S. Neelapu, Amanda Copeland, Barry I. Samuels, Evelyne M. Loyer, Yuan Ji, Anas Younes

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease

    Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease by Amer Beitinjaneh, Rima M. Saliba, L. Jeffrey Medeiros, Francesco Turturro, Gabriela Rondón, Martin Körbling, Luis Fayad, Michelle A. Fanale, Amin M. Alousi, Paolo Anderlini, Betül Oran, Uday Popat, Barbara Pro, Issa F. Khouri

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients

    Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients by Maria L. Espinosa, Morgan Nguyen, Amaia Saenz Aguirre, Maria Estela Martínez‐Escala, Jane Kim, Christina J. Walker, David Pontes, Jonathan I. Silverberg, Jaehyuk Choi, Barbara Pro, Laura B. Pincus, Joan Guitart, Xiaolong Zhou

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium

    Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium by Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin, Anas Younes, Scott E. Smith, Patrick J. Stiff, Eric P. Lester, Sanjiv Modi, L. Austin Doyle, Everett E. Vokes, Barbara Pro

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: